Market Access Analytics and Insight
Our Market Research & Analysis service is uniquely tailored for the medical device & Life…
Part IX of the Drug Tariff sets out the appliances and chemical reagents approved for prescribing at NHS expense in primary care in England and Wales, together with the reimbursement prices paid to dispensers. It is the principal reimbursement route for many medical devices used in the community, such as wound dressings, stoma and continence products, and certain diagnostic reagents. Manufacturers seeking primary care reimbursement must apply to NHS Prescription Services (part of the NHS Business Services Authority) for a product to be listed, providing evidence on clinical need, equivalence to existing products and price. Part IX listing is distinct from secondary care reimbursement through the NHS Payment Scheme and forms a key element of a device's overall reimbursement strategy.
Our Services
NICE HTA Strategy and Submission
Navigate the complexities of NICE Health Technology Assessment (HTA) submissions with our expert strategic guidance.…
Health Economics and Outcomes Research (HEOR)
Specialising in economic modelling for the medical device and life sciences sectors, our HEOR service…
Strategy Development
Leading in market access, Strategy Development from Health Analytical Solutions moves beyond just market entry…
Reimbursement Strategy and Support
Reimbursement Support, tailored for the complex NHS landscape, aids medical device and life sciences companies…
NHS Drug Tariff Submission Support
Our NHS Drug Tariff Submission Service offers specialised expertise in health economics, crucial for navigating…
Private healthcare
Delivering a comprehensive analysis of the UK's private healthcare sector, the Private Healthcare Landscape service…
Value Proposition Development for MedTech
Unlock the potential of your MedTech innovation with our Value Proposition Development service. At Health…
Primary Care Market Insights
Unlock the potential of the primary care market with our in-depth Primary Care Market Insights…
Stakeholder Engagement for Health Technologies
In the complex ecosystem of healthcare, effectively engaging with key stakeholders is fundamental to the…
Sustainability and NET Zero for MedTech
In an era where sustainability is not just an option but a necessity, MedTech companies…
Evidence Generation and Management
In the MedTech sector, the value of an innovation is increasingly measured not just by…
Dashboard Tools for Market Access
Navigating the complexities of market access requires not just data, but insights that can drive…
MedTech Sales Team Empowerment
The UK's National Health Service (NHS) represents a unique and complex market for MedTech sales.…
NHS MedTech Business Case Formulation
Securing NHS adoption for MedTech innovations demands not just outstanding technology but also a compelling…
© Health Analytical Solutions 2026